articleScienceSep 12, 2013GREEN OA

Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex

Shanghai Institute of Materia Medica · Scripps Research Institute · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry. Here we report the 2.7 angstrom-resolution crystal structure of human CCR5 bound to the marketed HIV drug maraviroc. The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry. A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity. These…

Citation impact

714
total citations
FWCI
35.95
Percentile
100%
References
37
Citations per year

Authors

19

Topics & keywords

Keywords
  • Maraviroc
  • CCR5 receptor antagonist
  • Chemokine receptor
  • Chemokine receptor CCR5
  • C-C chemokine receptor type 6
  • Entry inhibitor
  • CXCR4
  • Receptor
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.